Grape King Bio Future Growth
Future criteria checks 1/6
Grape King Bio is forecast to grow earnings and revenue by 7.5% and 6.5% per annum respectively. EPS is expected to grow by 4.9% per annum. Return on equity is forecast to be 14.6% in 3 years.
Key information
7.5%
Earnings growth rate
4.9%
EPS growth rate
Personal Products earnings growth | 16.5% |
Revenue growth rate | 6.5% |
Future return on equity | 14.6% |
Analyst coverage | Low |
Last updated | 26 Feb 2024 |
Recent future growth updates
Recent updates
Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 12,070 | 1,670 | 1,749 | 2,149 | 2 |
12/31/2024 | 11,529 | 1,599 | 1,545 | 2,045 | 4 |
12/31/2023 | 10,635 | 1,453 | 1,918 | 2,519 | N/A |
9/30/2023 | 10,559 | 1,456 | 2,019 | 2,571 | N/A |
6/30/2023 | 10,501 | 1,454 | 2,182 | 2,776 | N/A |
3/31/2023 | 10,558 | 1,501 | 2,410 | 2,977 | N/A |
12/31/2022 | 10,391 | 1,457 | 2,488 | 2,990 | N/A |
9/30/2022 | 10,186 | 1,426 | 2,287 | 2,664 | N/A |
6/30/2022 | 10,097 | 1,363 | 2,725 | 3,066 | N/A |
3/31/2022 | 9,879 | 1,304 | 2,218 | 2,539 | N/A |
12/31/2021 | 9,798 | 1,300 | 2,264 | 2,542 | N/A |
9/30/2021 | 9,623 | 1,281 | 2,320 | 2,590 | N/A |
6/30/2021 | 9,387 | 1,283 | 2,305 | 2,558 | N/A |
3/31/2021 | 9,131 | 1,242 | 1,683 | 2,669 | N/A |
12/31/2020 | 9,168 | 1,272 | 1,493 | 2,719 | N/A |
9/30/2020 | 9,138 | 1,279 | 1,264 | 2,507 | N/A |
6/30/2020 | 9,082 | 1,280 | 1,121 | 2,444 | N/A |
3/31/2020 | 9,234 | 1,309 | 1,570 | 2,185 | N/A |
12/31/2019 | 9,239 | 1,309 | 1,516 | 2,171 | N/A |
9/30/2019 | 9,193 | 1,288 | 1,296 | 2,146 | N/A |
6/30/2019 | 9,303 | 1,323 | 1,631 | 2,685 | N/A |
3/31/2019 | 9,265 | 1,298 | 1,310 | 2,415 | N/A |
12/31/2018 | 9,183 | 1,295 | 1,296 | 2,417 | N/A |
9/30/2018 | 9,302 | 1,331 | 1,432 | 2,450 | N/A |
6/30/2018 | 9,325 | 1,322 | 1,361 | 2,245 | N/A |
3/31/2018 | 9,317 | 1,353 | 1,317 | 2,183 | N/A |
12/31/2017 | 9,388 | 1,352 | 1,721 | 2,496 | N/A |
9/30/2017 | 9,130 | 1,295 | N/A | 2,310 | N/A |
6/30/2017 | 9,183 | 1,298 | N/A | 2,409 | N/A |
3/31/2017 | 9,180 | 1,272 | N/A | 2,790 | N/A |
12/31/2016 | 9,185 | 1,297 | N/A | 2,803 | N/A |
9/30/2016 | 8,667 | 1,219 | N/A | 2,737 | N/A |
6/30/2016 | 8,099 | 1,148 | N/A | 1,475 | N/A |
3/31/2016 | 7,606 | 1,097 | N/A | 1,486 | N/A |
12/31/2015 | 7,248 | 1,052 | N/A | 1,307 | N/A |
9/30/2015 | 6,995 | 1,035 | N/A | 1,197 | N/A |
6/30/2015 | 6,777 | 1,019 | N/A | 2,567 | N/A |
3/31/2015 | 6,548 | 986 | N/A | 2,053 | N/A |
12/31/2014 | 6,283 | 942 | N/A | 1,922 | N/A |
9/30/2014 | 6,038 | 907 | N/A | 1,760 | N/A |
6/30/2014 | 5,913 | 867 | N/A | 1,140 | N/A |
3/31/2014 | 5,797 | 857 | N/A | 1,479 | N/A |
12/31/2013 | 5,639 | 836 | N/A | 1,576 | N/A |
9/30/2013 | 5,438 | 745 | N/A | 1,303 | N/A |
6/30/2013 | 5,213 | 695 | N/A | 1,306 | N/A |
3/31/2013 | 4,859 | 632 | N/A | 1,234 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 1707's forecast earnings growth (7.5% per year) is above the savings rate (0.8%).
Earnings vs Market: 1707's earnings (7.5% per year) are forecast to grow slower than the TW market (19.3% per year).
High Growth Earnings: 1707's earnings are forecast to grow, but not significantly.
Revenue vs Market: 1707's revenue (6.5% per year) is forecast to grow slower than the TW market (10.1% per year).
High Growth Revenue: 1707's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 1707's Return on Equity is forecast to be low in 3 years time (14.6%).